Penny Stocks Today, Pharma Leaders Tomorrow
| Penny stocks can get a bad rap as overly aggressive investments that can make or break you based on a little rumor and a lot of luck. But penny stock investors know that these bargain investments come in all flavors – from ultra-cheap microcaps trading a few thousand shares a day on the pink sheets for a cent or two a piece, to legitimate but undervalued stocks that trade for a few dollars on major exchanges.
You don’t have to take flying leaps at random, unheard of penny stocks to see big gains. There are a number of very cheap small-caps out there that have decent balance sheets and lower risk. And some of my favorite right now are in the biotech sector, with big potential to break out on a drug approval or big pharma buyout. Here are 8 top biotech penny stocks to buy now: |
 3 Cheap Stocks to Rebuild Your Wealth |
DUSA Pharmaceuticals Inc. (DUSA)
| DUSA Pharmaceuticals Inc. (NASDAQ: DUSA) develops dermatology products for a variety of skin conditions. DUSA develops treatments for precancerous skin lesions, which can ultimately lead to skin cancer. Since last October, DUSA stock has jumped +132.1% compared to the Dow Jones and NASDAQ which have gained +11.8% and +12.6% respectively. Additionally, DUSA posted a quarterly revenue growth of +24.9% year-over-year in its last income statement along with a net profit margin of +2.2%. With a stock price of $2.45, this penny stock is an affordable buy right now. | 3 Cheap Stocks to Rebuild Your Wealth |
Rexahn Pharmaceuticals (RNN)
| Clinical stage biopharmaceutical company Rexahn Pharmaceuticals (AMEX: RNN) is currently searching for cures to cancer and disorders of the central nervous system. Since January, RNN has gained +66.2%, after it received a patent for its drug Archexin in March. Arhcexin was developed by RNN for use against five separate cancers. This penny stock is currently trading at $1.14, and has outperformed earnings estimates its last two quarters. | 3 Cheap Stocks to Rebuild Your Wealth |
AEterna Zentaris Inc. (AEZS)
| AEterna Zentaris Inc. (NASDAQ: AEZS) is a drug development company that specializes in oncology and endocrine therapy. Year-to-date AEZS stock has climbed an impressive +63.5% compared to smaller gains by the broader markets. This penny stock may only have a market cap of $110 million, but it remains a valuable buy with an affordable stock price of $1.31. | 3 Cheap Stocks to Rebuild Your Wealth |
Cyclacel Pharmaceuticals (CYCC)
| Headquartered in New Jersey, Cyclacel Pharmaceuticals (NASDAQ: CYCC) is a development-stage biopharmaceutical company. Cyclacel is working to discover, develop and commercialize mechanism-targeted drugs for the treatment of cancer and other disorders. Since January, this penny stock has jumped +57.7%. The stock soared in January when it was announced that its drug Seliciclib was found to be successful in killing lung cancer cells. CYCC is still riding high from the January stock spike. | 3 Cheap Stocks to Rebuild Your Wealth |
Inhibitex Inc. (INHX)
| Biopharmaceutical company Inhibitex Inc. (NASDAQ: INHX) develops products to prevent and treat serious infections. Since January, Inhibitex stock has climbed +109.8% compared to smaller gains by the broader markets. Currently trading $1.93, INHX is a penny stock worth buying based on its yearly performance and low stock price. | 3 Cheap Stocks to Rebuild Your Wealth |
Neuralstem Inc. (CUR)
| Neuralstem Inc. (AMEX: CUR) is involved with the development and commercialization of treatments for diseases of the central nervous system. The company works through the transplantation of human neural stem cells and small molecule drugs. Over the past 12 months, CUR’s stock has gained +61.2%, to where it currently trades at $2.40. | 3 Cheap Stocks to Rebuild Your Wealth |
Amarin Corp. (AMRN)
| Based in Connecticut, Amarin Corp. (NASDAQ: AMRN) is a clinical-stage biopharmaceutical company that is developing improved treatments for cardiovascular disease. Year-to-date, AMRN stock has climbed an impressive +96.5%. With a stock price of $2.82, AMRN is trading near its 52-week high of $3.23. | 3 Cheap Stocks to Rebuild Your Wealth |
Achillion Pharmaceuticals (ACHN)
| Achillion Pharmaceuticals (NASDAQ: ACHN) focuses on the discovery, development and commercialization of treatments for infectious diseases. ACHN focuses mainly on treatments for Hepatitis C. In the last year, this penny stock has jumped +58.5%, compared to smaller gains by the broader markets. Achillion has outperformed earnings estimate for two consecutive quarters, and is currently trading at $2.90. | 3 Cheap Stocks to Rebuild Your Wealth |
